Ackerman Capital Advisors, LLC

SEC CIK: 0001699506
Latest filing: Jul 30, 2026

SEC filings (opens in a new tab)

AMED holding history

Amedisys Inc in every 13F filed by Ackerman Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMED overview All 13F holders of AMED Full Q2 2026 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of AMED by Ackerman Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−1,000−100.0%	Sold out	Holders
Q2 2021	1,000	$245.0K	0.1%	00.0%	Unchanged	Holders
Q1 2021	1,000	$265.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.